DeAngelo DJ, Chen Y, Cassaday RD, Hibma JE, et al. Dose optimization of single-agent inotuzumab ozogamicin in adults with
relapsed/refractory acute lymphoblastic leukemia. Leuk Lymphoma 2026 Aug 18:1-11. doi: 10.1080/10428194.2026.2714343.
PMID: 42611806
|